{"schema_version":"secwatch.filing_event.v1","accession":"0001459839-26-000066","form_type":"8-K","ticker":"SIBN","cik":"0001459839","company_name":"SI-BONE, Inc.","filed_at":"2026-08-03T20:11:12+00:00","discovered_at":"2026-08-03T20:12:03.387188+00:00","generated_at":"2026-08-03T20:12:07.653130+00:00","sec_items":["2.02","9.01"],"event_type":"earnings","sentiment":"positive","materiality_score":0.75,"calibrated_materiality_score":0.75,"confidence":"high","headline":"SI-BONE Q2 revenue up 15.2% to $56.0M; raises FY 2026 revenue guidance to $231M-$233M","bullets":["Net loss improved 33.6% to $4.1M ($0.09 loss per share) vs $6.2M loss a year ago.","Adjusted EBITDA positive at $2.8M, up 178% from $1.0M in Q2 2025.","U.S. revenue $53.2M (+14.7%); active U.S. physician base grew 19% to 1,715.","FY 2026 revenue guidance raised to $231M-$233M (15-16% growth); operating expense growth lowered to ~12%.","Cash and equivalents $145.9M; positive cash from operations of $0.8M in Q2."],"urls":{"canonical":"https://secwatch.observer/filing/0001459839-26-000066","json":"https://secwatch.observer/filing/0001459839-26-000066.json","markdown":"https://secwatch.observer/filing/0001459839-26-000066.md","text":"https://secwatch.observer/filing/0001459839-26-000066.txt","edgar_index":"https://www.sec.gov/Archives/edgar/data/1459839/000145983926000066/0001459839-26-000066-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/1459839/000145983926000066/sibn-20260803.htm"},"model":{"generated_by":"deepseek-v4-flash:cloud@v2","generated_at":"2026-08-03T20:12:07.653130+00:00"},"review":{"review_status":"machine_generated","human_reviewed":false,"corrected":false,"correction_note":null,"correction_timestamp":null,"superseded_by":null,"related_filings":[]},"source_grounded_claims":[],"license":"Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer"}